Oncology Market Size, Share, Growth Analysis, By Cancer Diagnostics & Treatment (Cancer Diagnostics and Cancer Treatment), By Cancer Type (Lung Cancer, Breast Cancer), By End Use (Hospitals, Specialty Clinics), By Region -Industry Forecast 2026-2033

Report ID: SQSG35J2013 | Region: Global | Published Date: October, 2024
Pages: 157 | Tables: 103 | Figures: 76

Share your requirements to help us to customize the report.

I acknowledge that I have read the Privacy Policy

Confidentiality

We respect your privacy rights and safeguard your personal information. We prevent the disclosure of personal information to third parties.

Our Clients

Schineder Electric

KSIA - Korea Semiconductor Industry Association

Hitachi Astemo Limited

Samsung Electronics

Halvo holdings

NTT corporation

AGC Inc

Siemens AG

Unilever

Merck Pharmaceuticals

Atlas Copco

Hologic - Medical Technology company

Novartis

Henkel

Reckitt

Schineder Electric

KSIA - Korea Semiconductor Industry Association

Hitachi Astemo Limited

Samsung Electronics

Halvo holdings

NTT corporation

AGC Inc

Siemens AG

Unilever

Merck Pharmaceuticals

Atlas Copco

Hologic - Medical Technology company

Novartis

Henkel

Reckitt

FAQs

Oncology Market size was valued at USD 249.53 Billion in 2024 and is poised to grow from USD 277.48 Billion in 2025 to USD 648.73 Billion by 2033, growing at a CAGR of 11.2% during the forecast period (2026–2033).

Extensive development strategies such as partnership, acquisitions, mergers, and collaborations help in the considerable growth of the market. The key players operating in the market have also been working hard on their R&D projects, besides huge investments in the oncology field for some of the most innovative state-of-the-art cancer diagnosis and treatment methods. These players in the market focus on increasing their market share by introducing advanced oncology solutions while simultaneously trying to benefit from the ongoing market scenarios. 'Roche Holding AG ', 'Novartis International AG ', 'Pfizer Inc. ', 'Bristol-Myers Squibb Company ', 'Merck & Co., Inc. ', 'AstraZeneca plc ', 'Johnson & Johnson (Janssen Pharmaceuticals) ', 'Eli Lilly and Company ', 'Amgen Inc. ', 'Sanofi S.A. ', 'Bayer AG ', 'Takeda Pharmaceutical Company ', 'AbbVie Inc. ', 'Gilead Sciences, Inc. ', 'Astellas Pharma Inc. ', 'Celgene Corporation (acquired by Bristol-Myers Squibb) ', 'Regeneron Pharmaceuticals, Inc. ', 'GlaxoSmithKline plc (GSK) ', 'Daiichi Sankyo Company, Limited ', 'Seagen Inc. '

The main factor for oncology is the increasing incidence of cancer. The higher incidence of cancer is a result of several factors, which include the increasing number of older people and the alteration in lifestyle and exposure to the environment. The increased incidence level results in increasing patients who receive a diagnosis, which in turn influences the growth of the oncology industry by demanding cancer drugs, treatments, and diagnostics. This creates big market potential because of the need for specialized drugs, early diagnostics, and novel approaches to treatment.

Personalized Medicine: The key oncology market trends include personalized medicine. More cancer therapies are specific to the genetic profile of each individual patient. Targeted therapies, largely due to the rapid advancements recently made in genomics and molecular profiling, prove much more effective and have fewer side effects than conventional therapies. It is changing the face of cancer care by bettering the outcomes of patients, saving wasteful expenditure on treatments, and increasing treatment success. Advancement of minimally invasive techniques

North America holds the leading position in the oncology market in 2023, based on the massive number of cases of cancer prevalent in significant markets such as the United States. According to the American Cancer Society, more than 606,520 deaths were caused due to cancer in 2020 and over 1.8 million new cases of cancer were reported in the United States. The most frequently diagnosed cancer types are breast cancer, prostate cancer, colorectal cancer, and lung cancer in this region. In North America, the oncology market is expected to be led due to an advanced system of healthcare, high expenditures on health care, and a rapid embrace of new therapies used in the treatment of cancers. Interestingly, the incidence of deaths from cancer has declined by nearly 29% over the last two decades since these drugs have been in use since 1991.

Oncology Market Size, Share, Growth Analysis, By Cancer Diagnostics & Treatment (Cancer Diagnostics and Cancer Treatment), By Cancer Type (Lung Cancer, Breast Cancer), By End Use (Hospitals, Specialty Clinics), By Region -Industry Forecast 2026-2033

Share your requirements to help us to customize the report.

Confidentiality

Our Clients

FAQs

What is the global market size of Oncology Market?

Who are the key vendors in the Oncology Market?

What is the key driver of Oncology Market?

What is the key market trend for Oncology Market?

Which region accounted for the largest share in Oncology Market?

$5,300